Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-01-11A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of VAL-339851 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2020-12-19Safety and Efficacy of Endotracheal Intubation by Paramedics in Suspected/Confirmed COVID-19 Patients Under Cardiac Arrest Using Vie Scope Laryngoscope
-
CLINICAL_TRIALS study record update · 2020-12-17Collection of Serum Samples From Children 6 Months to < 9 Years of Age Who Received Fluzone® Quadrivalent and Adults ≥ 65 Years of Age Who Received Fluzone® High-Dose, Influenza Vaccines, 2019-2020 Formulations
-
CLINICAL_TRIALS study record update · 2020-12-17Infection Tracking in Travellers (ITIT)
-
CLINICAL_TRIALS study record update · 2020-12-17Reducing the Burden of Influenza After Solid-Organ Transplantation: the STOP-FLU Trial [Swiss Trial in Solid Organ Transplantation on Prevention of Influenza]
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-12-03Study of Antiviral Therapy of Influenza and ARVI With Kagocel ® in Children
-
CLINICAL_TRIALS study record update · 2020-12-01A Randomized Double-Blind, Placebo Controlled, Phase I Study of the Safety, Tolerability and Immunogenicity of a Live Attenuated H1N1 Vaccine in Healthy Individuals
-
CLINICAL_TRIALS study record update · 2020-11-30A Phase III, Randomized, Double-Blind Placebo-Controlled, Multicenter Study To Evaluate the Efficacy and Safety of Baloxavir Marboxil in Combination With Standard-of-Care Neuraminidase Inhibitor in Hospitalized Participants With Severe Influenza
-
CLINICAL_TRIALS study record update · 2020-11-16Double-blind Randomized Placebo-controlled Comparative Multicenter Study to Assess the Safety, Tolerability and Efficacy of XC221 in a Dose of 200mg Per Day in Patients With Uncomplicated Influenza or Other ARVI
-
CLINICAL_TRIALS study record update · 2020-11-12Kagocel for Oral Administration for the Prevention of Influenza and Other Acute Respiratory Viral Diseases in Young People
-
CLINICAL_TRIALS study record update · 2020-11-10Mucosal Correlates of Protection After Influenza Viral Challenge of Vaccinated and Unvaccinated Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-11-02Study of the Use of Kagocel® for the Prevention of ARVI and Influenza During the Epidemic Rise in the Incidence of Diseases in Adults
-
CLINICAL_TRIALS study record update · 2020-10-23Persistence of Influenza Vaccine-induced Antibody in Lung Transplant Patients and Healthy Individuals Beyond the Season
-
CLINICAL_TRIALS study record update · 2020-10-23Antibody Responses to Influenza Vaccine in Pre- and Post-lung Transplant Patients
-
CLINICAL_TRIALS study record update · 2020-10-23Effect of Annual Influenza Immunization on Antibody Response in Lung Transplant Patients
-
CLINICAL_TRIALS study record update · 2020-10-23Persistence of Influenza Vaccine-induced Antibodies in Lung Transplant Patients Between Seasons
-
CLINICAL_TRIALS study record update · 2020-10-23Lung Transplant Patients' T Cell Responses to Influenza Vaccine Viruses Between Seasons
-
CLINICAL_TRIALS study record update · 2020-10-23Influenza Vaccine Antibody Response and 6-month Persistence in Lung Transplant Recipients Using Two Definitions of Seroprotection
-
CLINICAL_TRIALS study record update · 2020-10-22An Open-Label Phase 3 Study to Assess the Immunogenicity and Safety of a Vero Cell-Derived Trivalent Seasonal Influenza Vaccine, Strain Composition 2010/2011, in an Adult and Elderly Population
-
CLINICAL_TRIALS study record update · 2020-10-22A Randomized Controlled Trial Comparing High-dose vs. Standard Influenza Vaccine in Adult Solid Organ Transplant Recipients
-
CLINICAL_TRIALS study record update · 2020-10-20Safety and Immunogenicity of Influenza Vaccine During the First Post-Transplant Year in Solid Organ Transplant Recipients
-
CLINICAL_TRIALS study record update · 2020-10-19VRC 316: A Phase I Open-Label Clinical Trial To Evaluate Dose, Safety, Tolerability, And Immunogenicity Of An Influenza HA Ferritin Vaccine, Alone Or In Prime-Boost Regimens With An Influenza DNA Vaccine In Healthy Adults
-
CLINICAL_TRIALS study record update · 2020-10-08Performance Feedback in Health Care
-
CLINICAL_TRIALS study record update · 2020-09-30A Phase I Randomized, Double-blind, Placebo-controlled, Dose Finding Clinical Trial to Evaluate the Safety and Immunogencity of H7N9 Influenza Antigen Adjuvanted With 2 Different Adjuvant Formulations in Healthy Adult Volunteers in Brazil
-
CLINICAL_TRIALS study record update · 2020-09-09Efficacy of Different Regimens in Influenza Postexposure Chemoprophylaxis With Oral Neuraminidase Inhibitor in Children